|
The Global Bioinformatics IndustryPublished by: Scope eKnowledge Center Ltd. Published: Oct. 1, 2002 - 132 Pages Table of ContentsAn Introduction To Bioinformatics
AbstractThe human body is a wonderful machine. Attempts have been made since time immemorial to understand the functioning of this machine. The study of biology has, over the years, moved on from being "in vivo"(within an organism) to "in vitro" (outside an organism) and now biology is moving "in silico" (using electronics and computers for biological research). The study of life sciences has matured to the extent of making cloning of living beings a reality.Of late, the amount of information being churned out by the field of biology has jumped manifold and now requires the extensive use of computers of the management of this information. The field of bioinformatics that addresses this need of biology has become an industry in its own right with the pharmaceutical and biotechnology industries being dependent on it for their growth. The bursting of the dotcom bubble in 2000 saw investors and venture capitalists flocking to the biotechnology industry in general and bioinformatics in particular. With current revenues at around $ 840 million, Scope forecasts the bioinformatics market to become more dominant in the future and increase to around $1.82 billion by 2007. The growth rate is expected to stabilize at 17 percent per annum until 2007 as the sequencing of the human genome nears completion in 2003. Over the past years, bioinformatics has gained acceptance among number of markets especially in pharmaceutical, biotechnology, industrial biotechnology and agricultural biotechnology (agbiotech). The industry is highly fragmented and is seeing increased consolidation in the form of alliances and acquisitions with the action being primarily concentrated in the US and Europe. The overall competition has changed over the past few years with IT super powers entering this industry as also Pharma majors. This is expected to continue in the same way. Given this scenario, the industry is witnessing a lot more competition, with companies entering into strategic alliances to remain more competitive in the market. Issues such as data management, data standardization and patents continue to dominate the industry. Major players in the bioinformatics industry include Accelrys, Compugen, Celera Genomics, IBM Life Sciences Solutions, Incyte Genomics, LION Bioscience, Structural Bioinformatics among others. This report critically examines and provides insights into state of the Global Bioinformatics Industry, as it exists today including market segmentation, current market size and its forecast across segments, major players, end user analysis, key industry drivers etc. Report also provides brief profiles of some of the leading players in the market. |
|
|||
|
About MarketResearch.com
|
||||